These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30118378)

  • 1. Microbial biotransformation - an important tool for the study of drug metabolism.
    Salter R; Beshore DC; Colletti SL; Evans L; Gong Y; Helmy R; Liu Y; Maciolek CM; Martin G; Pajkovic N; Phipps R; Small J; Steele J; de Vries R; Williams H; Martin IJ
    Xenobiotica; 2019 Aug; 49(8):877-886. PubMed ID: 30118378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From known knowns to known unknowns: predicting in vivo drug metabolites.
    Pelkonen O; Tolonen A; Korjamo T; Turpeinen M; Raunio H
    Bioanalysis; 2009 May; 1(2):393-414. PubMed ID: 21083174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of microbial biotransformation for the new drug discovery using natural drugs as substrates.
    Venisetty RK; Ciddi V
    Curr Pharm Biotechnol; 2003 Jun; 4(3):153-67. PubMed ID: 12769760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial Bioconversion: A Regio-specific Method for Novel Drug Design and Toxicological Study of Metabolites.
    Yousuf M; Jamil W; Mammadova K
    Curr Pharm Biotechnol; 2019; 20(14):1156-1162. PubMed ID: 31258075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug metabolism in microorganisms.
    Murphy CD
    Biotechnol Lett; 2015 Jan; 37(1):19-28. PubMed ID: 25179825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial models for drug metabolism.
    Azerad R
    Adv Biochem Eng Biotechnol; 1999; 63():169-218. PubMed ID: 9933985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of relative MS response factors of drug metabolites for semi-quantitative assessment of chemical liabilities in drug discovery.
    Blanz J; Williams G; Dayer J; Délémonté T; Gertsch W; Ramstein P; Aichholz R; Trunzer M; Pearson D
    J Mass Spectrom; 2017 Apr; 52(4):210-217. PubMed ID: 28152561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial biotransformation: a tool for drug designing (Review).
    Pervaiz I; Ahmad S; Madni MA; Ahmad H; Khaliq FH
    Prikl Biokhim Mikrobiol; 2013; 49(5):435-49. PubMed ID: 25474866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolite identification in drug discovery.
    Watt AP; Mortishire-Smith RJ; Gerhard U; Thomas SR
    Curr Opin Drug Discov Devel; 2003 Jan; 6(1):57-65. PubMed ID: 12613277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of drug metabolism by hydroxylated metabolites: cross-inhibition and specificity.
    Soda DM; Levy G
    J Pharm Sci; 1975 Dec; 64(12):1928-31. PubMed ID: 1206483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesis.
    Schroer K; Kittelmann M; Lütz S
    Biotechnol Bioeng; 2010 Aug; 106(5):699-706. PubMed ID: 20506361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis of drug metabolites and quantitation using NMR spectroscopy for use in pharmacologic and drug metabolism studies.
    Walker GS; Bauman JN; Ryder TF; Smith EB; Spracklin DK; Obach RS
    Drug Metab Dispos; 2014 Oct; 42(10):1627-39. PubMed ID: 25053618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologically active drug metabolites: impact on drug discovery and pharmacotherapy.
    Obach RS
    Pharmacol Rev; 2013 Apr; 65(2):578-640. PubMed ID: 23406671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical metabolite synthesis and profiling: Mimicking in vivo biotransformation reactions.
    Chhatrapati Bisen A; Nashik Sanap S; Agrawal S; Biswas A; Sankar Bhatta R
    Bioorg Chem; 2023 Oct; 139():106722. PubMed ID: 37453238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative metabolism of BDE-99 by human liver microsomes: predominant role of CYP2B6.
    Erratico CA; Szeitz A; Bandiera SM
    Toxicol Sci; 2012 Oct; 129(2):280-92. PubMed ID: 22738989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of urinary metabolites of xenobiotics as a non-invasive technique in toxicology.
    Breimer DD
    Arch Toxicol Suppl; 1982; 5():162-78. PubMed ID: 6954894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accessing Drug Metabolites via Transition-Metal Catalyzed C-H Oxidation: The Liver as Synthetic Inspiration.
    Genovino J; Sames D; Hamann LG; Touré BB
    Angew Chem Int Ed Engl; 2016 Nov; 55(46):14218-14238. PubMed ID: 27723189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolism.
    Baillie TA; Rettie AE
    Drug Metab Pharmacokinet; 2011; 26(1):15-29. PubMed ID: 20978360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical reaction vector embeddings: towards predicting drug metabolism in the human gut microbiome.
    Mallory EK; Acharya A; Rensi SE; Turnbaugh PJ; Bright RA; Altman RB
    Pac Symp Biocomput; 2018; 23():56-67. PubMed ID: 29218869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotransformation of 2,2',4,4'-tetrabromodiphenyl ether (BDE-47) by human liver microsomes: identification of cytochrome P450 2B6 as the major enzyme involved.
    Erratico CA; Szeitz A; Bandiera SM
    Chem Res Toxicol; 2013 May; 26(5):721-31. PubMed ID: 23537005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.